Research & Development News
Research & Development news
-
News Parenteral delivery under control
In this second article exploring new methods of quantifying and analysing the performance characteristics of controlled release products outlines tests for parenteral forms of controlled delivery systems. -
News No hiding place for herpes
Attempts to protect the population from the contagious herpes virus have been hindered by its ability to hide from the bodys immune system. The biotech company BioVex explains how its new vaccine addresses this problem. -
News Respiratory syncytial virus ALN-RSV-01
US biotech Alnylam is taking another tack it is developing an RNAi-based drug to attack respiratory syncytial virus, or RSV. -
News Improving trial data management
Wipro Technologies highlights how its electronic solution has helped to manage a clients process of data collection and trial management in a cost-effective and efficient way. -
News No need for the cooler
The provision of instantly injectable, thermo-stable vaccines in tropical temperatures could make cold storage problems a thing of the past. Nova Bio-Pharma Technologies believes it has the technology. -
News Heart failure omecamtiv mecarbil
Omecamtiv mecarbil1 is being developed by Cytokinetics in collaboration with Amgen. -
News Knockout medicines
Dr Sarah Houlton reviews recent development of gene manipulation technology and its potential application in providing new medicines. -
News Anticoagulant edoxaban tosilate
There are several points along the clotting cascade that could be targets for anticoagulants.Edoxaban is being developed by Daiichi Sankyo, and is showing promise in clinical trials. -
News Making the French connection
The annual CPHI events move back to Paris next month. Hilary Ayshford questioned the organisers on their expectations for the shows and the future outlook. -
News Microbial control of combo devices
New drug delivery systems or combo devices are becoming more prevalent in the market. Mark Botting, UK commercial manager, Isotron, reviews some current challenges and potential future changes in sterilising drug device combination products... -
News Management cost vs value
Clinical trials are usually tendered for and awarded on cost. Paul Naybour, md at Parallel Project Training, and Roger Joby, project management consultant at 1to1to1, argue that the focus should be on value rather than cost. -
News Whats in a seal?
Elastomer maker Precision Polymer Engineering and ChargePoint Technology explain how the optimum elastomer was selected for a split butterfly valve. -
News International Society for Cellular Therapy (ISCT) launches Cell Therapy Industry Partnership
Many companies in the cell therapy regenerative medicine market including Roche, Genzyme, Athersys, Miltenyi Biotec, Hospira, Lonza and Life Technologies will join ISCT to launch a series of new initiatives that will create greater strategic alignment ... -
News FDA approves ella tablets for prescription emergency contraception
The U.S. Food and Drug Administration today approved ella? (ulipristal acetate) tablets for emergency contraception. The prescription-only product prevents pregnancy when taken orally within 120 hours (five days) after a contraceptive failure or unprot... -
News StemCells reports breakthrough using human neural stem cells to restore motor function in chronic spinal cord injury
StemCells, Inc. announced the publication of new preclinical data demonstrating that the companys proprietary human neural stem cells restore lost motor function in mice with chronic spinal cord injury. -
News Genetix's ClonePix FL system gets US patent
Genetix, a leading provider of solutions for imaging and image analysis, announces that it was granted a patent, US 7,776,584 on August 17, 2010. Aspects of this patent are incorporated into ClonePix FL, which is used for the screening and selection of... -
News Strand inks pact with MSCC for translational cancer research, pilot study on head & neck cancer takes off
Strand Life Sciences has entered into a strategic collaboration with Mazumdar Shaw Comprehensive Cancer Centre (MSCC), part of the multi-specialty hospital, Narayana Hrudalaya, in the area of translational cancer research. -
News FDA Proposes Withdrawal of Low Blood Pressure Drug
The U.S. Food and Drug Administration proposed to withdraw approval of the drug midodrine hydrochloride, used to treat the low blood pressure condition orthostatic hypotension, because required post-approval studies that verify the clinical benefit of ... -
News Ipilimumab Receives FDA Priority Review Designation
Bristol-Myers Squibb Company (NYSE: BMY) has announced that the U.S. Food and Drug Administration (FDA) has accepted, for filing and review, the Biologics License Application (BLA) for ipilimumab for the treatment of adult patients with advanced melano... -
News A golden era for catalysts
Natures keys catalysts can unlock doors to better product yields and faster reactions. Dr Sarah Houlton reviews the latest research using carbon nanofibres, enzymes and even gold for producing new catalysts. -
News Moisture analysis
Freelance Sarah Webster describes how Biopharma Technology is using laser-based headspace moisture analysis for rapid and non-destructive moisture determination of freeze-dried pharmaceutical products.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance